OncoQuest Pharmaceuticals Inc Working Capital to Net Assets Ratio
OncoQuest Pharmaceuticals Inc working capital to net assets ratio. OncoQuest Pharmaceuticals Inc (078590) has a Working Capital to Net Assets ratio of 15.2% as of March 2026. Working capital of ₩11.42 Billion (current assets of ₩30.12 Billion minus current liabilities of ₩18.71 Billion) is measured against net assets of ₩74.92 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 078590 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of OncoQuest Pharmaceuticals Inc (2014–2025)
Working capital to net assets ratio of OncoQuest Pharmaceuticals Inc from 2014 to 2025. This chart shows how OncoQuest Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 15.2%, reflecting working capital of ₩11.42 Billion against net assets of ₩74.92 Billion KRW. See 078590 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
OncoQuest Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2014–2025)
OncoQuest Pharmaceuticals Inc working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for OncoQuest Pharmaceuticals Inc from 2014 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see OncoQuest Pharmaceuticals Inc (078590) total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -27.7% | ₩-13.55 Billion | ₩48.94 Billion | ₩18.40 Billion | ₩31.95 Billion | ▼ -7.5 pp |
| 2024 | -20.2% | ₩-9.69 Billion | ₩47.92 Billion | ₩16.90 Billion | ₩26.60 Billion | ▼ -73.6 pp |
| 2023 | 53.4% | ₩23.17 Billion | ₩43.42 Billion | ₩32.92 Billion | ₩9.75 Billion | ▼ -24.2 pp |
| 2022 | 77.6% | ₩26.92 Billion | ₩34.70 Billion | ₩34.30 Billion | ₩7.38 Billion | ▲ +72.8 pp |
| 2019 | 4.8% | ₩1.19 Billion | ₩24.71 Billion | ₩45.79 Billion | ₩44.60 Billion | ▲ +14.1 pp |
| 2018 | -9.3% | ₩-2.42 Billion | ₩26.14 Billion | ₩39.80 Billion | ₩42.22 Billion | ▼ -33.5 pp |
| 2017 | 24.3% | ₩4.21 Billion | ₩17.32 Billion | ₩13.49 Billion | ₩9.29 Billion | ▼ -14.2 pp |
| 2016 | 38.5% | ₩5.51 Billion | ₩14.30 Billion | ₩11.68 Billion | ₩6.17 Billion | ▲ +15.7 pp |
| 2015 | 22.8% | ₩2.73 Billion | ₩11.98 Billion | ₩8.85 Billion | ₩6.12 Billion | ▲ +20.6 pp |
| 2014 | 2.2% | ₩156.36 Million | ₩7.10 Billion | ₩8.38 Billion | ₩8.22 Billion | — |